119th Congress · introduced in the House · May 4, 2026
Advancing Safe Medications for Moms and Babies Act of 2026
Official title from Congress.gov
Latest action (May 4, 2026): Referred to the House Committee on Energy and Commerce.
View on Congress.govPolicy area: Health
No official summary has been published for this bill.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Introduced in House
Actions from Congress.gov, newest first.
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 24, 2026.
4 citations.
AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS · lobbying firm or registrant: AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$250,000
Spent on own lobbying
Abortion access (general); Access to mifepristone (general); Contraception (general); Maternal mortality and morbidity (general); H.R. 8651/S. _____, Advancing Safe Medications for Moms and Babies Act; Obstetric and gynecologic care in rural and underserved areas (general); impact of closures of la…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
1DAY SOONER ACTION PROJECT INC. · lobbying firm or registrant: 1DAY SOONER ACTION PROJECT INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · amended · posted Oct 18, 2026 · issue area: Health Issues
$40,000
Spent on own lobbying
…e Clinical Trial Modernization Act (Sen. Scott), including participant compensation provisions. Inclusion of pregnant individuals in clinical trials, including H.R. 8651, the Advancing Safe Medications for Moms and Babies Act of 2026 (Rep. Castor, Sen. Hickenlooper). FDA Sentinel system and real-world evidence provisions for po…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
1DAY SOONER ACTION PROJECT INC. · lobbying firm or registrant: 1DAY SOONER ACTION PROJECT INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · amended · posted Oct 18, 2026 · issue area: Medical/Disease Research/Clinical Labs
$40,000
Spent on own lobbying
…e Clinical Trial Modernization Act (Sen. Scott), including participant compensation provisions. Inclusion of pregnant individuals in clinical trials, including H.R. 8651, the Advancing Safe Medications for Moms and Babies Act of 2026 (Rep. Castor, Sen. Hickenlooper). FDA Sentinel system and real-world evidence provisions for po…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS · lobbying firm or registrant: AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Health Issues
$96,000
Spent on own lobbying
Abortion access (general); Access to mifepristone (general); Contraception (general); Maternal mortality and morbidity (general); H.R. 8651/S. _____, Advancing Safe Medications for Moms and Babies Act; Obstetric and gynecologic care in rural and underserved areas (general); impact of closures of la…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing